Data / Form D filings / BirchBioMed Inc.
BirchBioMed Inc.: Form D filings
BirchBioMed Inc., a biotechnology company in King City, Ontario, Canada, filed 8 Form D notices with the SEC between 2016 and 2025. The latest, on October 1, 2025, reports $2.5 million sold of a $5 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 130 KINGSCROSS DRIVE, King City, Ontario, Canada, L7B 1
- Phone
- (905) 833-3414
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1670747
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Amendment | $5,000,000 | $2,480,000 | $2,520,000 | 18 | Jun 27, 2025 | sec.gov |
| Jul 11, 2025 | New notice | $3,000,000 | $175,000 | $2,825,000 | 5 | Jun 27, 2025 | sec.gov |
| Nov 1, 2021 | New notice | $2,900,000 | $596,013 | $2,303,987 | 5 | Oct 7, 2021 | sec.gov |
| Aug 28, 2020 | New notice | $2,900,000 | $398,715 | $2,501,285 | 10 | Aug 25, 2020 | sec.gov |
| Feb 5, 2020 | Amendment | $10,000,000 | $5,302,550 | $4,697,450 | 97 | May 20, 2016 | sec.gov |
| Feb 25, 2019 | Amendment | $10,000,000 | $3,970,550 | $6,029,450 | 65 | May 20, 2016 | sec.gov |
| Sep 20, 2017 | Amendment | $10,000,000 | $1,405,019 | $8,594,981 | 20 | Jun 14, 2016 | sec.gov |
| Mar 30, 2016 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Sardano | Director | |
| John Verbeck | Executive Officer | |
| Mark Miller | Executive Officer, Director, Promoter | |
| Teresa Bair | Director | |
| Herve Girsault | Executive Officer | |
| Charles Ellis | Director | |
| Carlos Camozzi | Executive Officer | |
| Susan Elliott | Executive Officer, Director, Promoter |
Every Form D from the week of Sep 29, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BirchBioMed Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.